Increase in plasma HDL-cholesterol in hypertensive patients treated with enalapril

G. Perani, C. Muggia, A. Martignoni, A. Bongarzoni, A. Radaelli, F. Testa, G. Finardi

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The effects of enalapril on plasma lipoproteins were evaluated in an open study of 12 normolipidemic outpatients with mild-to-moderate essential hypertension (World Health Organization stages I and II). After a two-week washout period, during which placebo was given, the patients received 20 to 40 mg/day of enalapril for 16 weeks. Treatment with enalapril was associated with significant increases in levels of HDL cholesterol (mean, 23%; P2 (mean, 43%; P3 also rose (mean, 14%; P

Original languageEnglish
Pages (from-to)635-639
Number of pages5
JournalClinical Therapeutics
Volume9
Issue number6
Publication statusPublished - 1987

Fingerprint

Enalapril
HDL Cholesterol
Lipoproteins
Outpatients
Placebos
Therapeutics

ASJC Scopus subject areas

  • Pharmacology

Cite this

Increase in plasma HDL-cholesterol in hypertensive patients treated with enalapril. / Perani, G.; Muggia, C.; Martignoni, A.; Bongarzoni, A.; Radaelli, A.; Testa, F.; Finardi, G.

In: Clinical Therapeutics, Vol. 9, No. 6, 1987, p. 635-639.

Research output: Contribution to journalArticle

Perani, G. ; Muggia, C. ; Martignoni, A. ; Bongarzoni, A. ; Radaelli, A. ; Testa, F. ; Finardi, G. / Increase in plasma HDL-cholesterol in hypertensive patients treated with enalapril. In: Clinical Therapeutics. 1987 ; Vol. 9, No. 6. pp. 635-639.
@article{460fdab83ea745b598a6d444ef3df39e,
title = "Increase in plasma HDL-cholesterol in hypertensive patients treated with enalapril",
abstract = "The effects of enalapril on plasma lipoproteins were evaluated in an open study of 12 normolipidemic outpatients with mild-to-moderate essential hypertension (World Health Organization stages I and II). After a two-week washout period, during which placebo was given, the patients received 20 to 40 mg/day of enalapril for 16 weeks. Treatment with enalapril was associated with significant increases in levels of HDL cholesterol (mean, 23{\%}; P2 (mean, 43{\%}; P3 also rose (mean, 14{\%}; P",
author = "G. Perani and C. Muggia and A. Martignoni and A. Bongarzoni and A. Radaelli and F. Testa and G. Finardi",
year = "1987",
language = "English",
volume = "9",
pages = "635--639",
journal = "Clinical Therapeutics",
issn = "0149-2918",
publisher = "Excerpta Medica Inc.",
number = "6",

}

TY - JOUR

T1 - Increase in plasma HDL-cholesterol in hypertensive patients treated with enalapril

AU - Perani, G.

AU - Muggia, C.

AU - Martignoni, A.

AU - Bongarzoni, A.

AU - Radaelli, A.

AU - Testa, F.

AU - Finardi, G.

PY - 1987

Y1 - 1987

N2 - The effects of enalapril on plasma lipoproteins were evaluated in an open study of 12 normolipidemic outpatients with mild-to-moderate essential hypertension (World Health Organization stages I and II). After a two-week washout period, during which placebo was given, the patients received 20 to 40 mg/day of enalapril for 16 weeks. Treatment with enalapril was associated with significant increases in levels of HDL cholesterol (mean, 23%; P2 (mean, 43%; P3 also rose (mean, 14%; P

AB - The effects of enalapril on plasma lipoproteins were evaluated in an open study of 12 normolipidemic outpatients with mild-to-moderate essential hypertension (World Health Organization stages I and II). After a two-week washout period, during which placebo was given, the patients received 20 to 40 mg/day of enalapril for 16 weeks. Treatment with enalapril was associated with significant increases in levels of HDL cholesterol (mean, 23%; P2 (mean, 43%; P3 also rose (mean, 14%; P

UR - http://www.scopus.com/inward/record.url?scp=0023635119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023635119&partnerID=8YFLogxK

M3 - Article

C2 - 2830973

AN - SCOPUS:0023635119

VL - 9

SP - 635

EP - 639

JO - Clinical Therapeutics

JF - Clinical Therapeutics

SN - 0149-2918

IS - 6

ER -